$1.2 Million in Grants for Alzheimer’s, Down Syndrome Research

The Alzheimer’s Association, the Linda Crnic Institute for Down Syndrome and the Global Down Syndrome Foundation today launched a new research initiative to better understand the development of Alzheimer’s disease in individuals with Down syndrome (DS) and translate the research into improved treatments for people at risk to develop Alzheimer’s.

The organizations are making a total of $1.2 million available for new research projects, and have issued a Request for Applications (RFA) titled Understanding the Development and Devising Treatments for Alzheimer’s Disease in Individuals with Down Syndrome.

“Through this new initiative, we hope to better understand the mechanisms that lead to Alzheimer’s in people with Down syndrome in order to get us a big step closer to new treatments,” said William Thies, Ph.D., Alzheimer’s Association chief medical and scientific officer. “The eventual goal is to advance the charge toward better Alzheimer’s therapies for people with Down syndrome and for people without it.”

“We’re pleased to have leaders that represent a significant scientific brain trust leading this program, and we are grateful to have the scientific review apparatus and peer reviewers provided by the Alzheimer’s Association,” said Michelle Sie Whitten, Executive Director of the Global Down Syndrome Foundation.

To read the full press release, click here.

Recent Posts

• Exclusive Interview with the DSA of Southern New Jersey’s Co-Executive Directors #2
• U.S. Senate Passes DeOndra Dixon INCLUDE Project Act
• Celebrities Terrell Davis, John C. McGinley & Caterina Scorsone Join the Largest Down Syndrome Fundraiser in the World
• GLOBAL Experts Educate Families, Advance Collaboration, and Break Attendance Records at the DSAIA Leadership Conference and NDSC Annual Convention
• GLOBAL Self-Advocates Build Muscle and Meaningful Connections in the Education Center